Terms And Conditions
  1. Home
  2. Terms And Conditions
Radiopharm Theranostics Limited (ASX: RAD): R...
By ACE Investors / 13 Jun 2023
Read More
Vitura Health Limited–Significant Revenue G...
By ACE Investors / 09 Jun 2023
Read More
Mayne Pharma Group Limited – Momentum Conti...
By ACE Investors / 02 Jun 2023
Read More
A Health Care Equipment Provider with Solid R...
By ACE Investors / 26 May 2023
Read More
EBR Systems Inc (ASX: EBR): EBR reported posi...
By ACE Investors / 25 May 2023
Read More
Immutep Limited(ASX: IMM) A Biotech Company w...
By ACE Investors / 22 May 2023
Read More
Opthea Limited (ASX: OPT): Opthea made signif...
By ACE Investors / 19 May 2023
Read More
Proteomics International Laboratories Ltd (AS...
By ACE Investors / 19 May 2023
Read More
Althea Group Holdings Limited (ASX: AGH): AGH...
By ACE Investors / 16 May 2023
Read More
Neuren Pharmaceuticals Limited(ASX: NEU) A Bi...
By ACE Investors / 16 May 2023
Read More
Artrya Limited (ASX: AYA): Artrya submitted Q...
By ACE Investors / 15 May 2023
Read More
Pharmaxis Ltd(ASX: PXS): Pharmaxis announced ...
By ACE Investors / 10 May 2023
Read More
ABN No: 70 637 702 188 | ACN NO: 637 702 188
Copyright © 2024 ACE Investors. All Right Reserved. Design by Ace Investors